Abstract:Essentials There are many hereditary platelet disorders (HPD) but diagnosing these is challenging. We provide a method to diagnose several HPDs using standard blood smears requiring < 100 µL blood. By this approach, the underlying cause of HPD was characterized in ~25-30% of referred individuals. The method facilitates diagnosis of HPD for patients of all ages around the world. Summary: Background Many hereditary thrombocytopenias and/or platelet function disorders have been identified, but diagnosis of these conditions remains challenging. Diagnostic laboratory techniques are available only in a few specialized centers and, using fresh blood, often require the patient to travel long distances. For the same reasons, patients living in developing countries usually have limited access to diagnosis. Further, the required amount of blood is often prohibitive for pediatric patients. Objectives By a collaborative international approach of four centers, we aimed to overcome these limitations by developing a method using blood smears prepared from less than 100 μL blood, for a systematic diagnostic approach to characterize the platelet phenotype. Methods We applied immunofluorescence labelling (performed centrally) to standard air-dried peripheral blood smears (prepared locally, shipped by regular mail), using antibodies specific for proteins known to be affected in specific hereditary platelet disorders. Results By immunofluorescence labelling of blood smears we characterized the underlying cause in 877/3217 (27%) patients with suspected hereditary platelet disorders (HPD). Currently about 50 genetic causes for HPD are identified. Among those, the blood smear method was especially helpful to identify MYH9 disorders/MYH9-related disease, biallelic Bernard-Soulier syndrome, Glanzmann thrombasthenia and gray platelet syndrome. Diagnosis could be established for GATA1 macrothrombocytopenia, GFI1B macrothrombocytopenia, ß1-tubulin macrothrombocytopenia, filamin A-related thrombocytopenia and Wiskott-Aldrich syndrome. Conclusion Combining basic and widely available preanalytical methods with the immunomorphological techniques presented here, allows detailed characterization of the platelet phenotype. This supports genetic testing and facilitates diagnosis of hereditary platelet disorders for patients of all ages around the world.

Establishment of reference panel for human platelet antigen genotyping

A novel approach to simultaneous genotyping of human platelet antigen systems and human leucocyte antigen class I loci using PacBio long‐read sequencing

HPA1-29w Genotyping and the Foundation for the Platelet Apheresis Registry in Jiangsu Province of China by MassARRAY Spectrometry

Genetic Polymorphisms of HPA 1-6, 15 Systems in the Hangzhou Population and Their Role in the Management of Platelet Transfusion Refractoriness

Frequency of human platelet antigens (HPA) in the Greek population as deduced from the first registry of HPA‐typed blood donors

Application of DHPLC in human genomic SNP screening and genotyping for all-trans-retinol dehydrogenase

Analysis on genetic polymorphism of human platelet antigen HPA1-6,15 systems to platele trtansufsions

Human platelet antigen allelic diversity in Peninsular Malaysia

Association of LRP5/6 Gene Polymorphism and Hirschsprung's Disease

Rapid and sensitive identification of glycoprotein h genotypes in clinical human cytomegalovirus samples.

[Expert consensus on the standardization and clinical application of genotyping for human leukocyte antigens]

Development and validation of a custom panel including 183 Y-SNPs for Chinese Y-chromosomal haplogroups dissection using a MALDI-TOF MS system

Generation of human antibodies targeting human platelet antigen (HPA)‐1a

Diagnosis of inherited platelet disorders on a blood smear: a tool to facilitate worldwide diagnosis of platelet disorders

Selection and Validation of Reference Genes for Pan-Cancer in Platelets Based on RNA-Sequence Data

Platelet transfusions in haploidentical haematopoietic stem cell allograft candidates: Protecting HLA‐A and HLA‐B antigens through eplet analysis

Platelet HLA gene bank digital matching technology for platelet transfusion refractory patients with malignant tumors: a case report

How should we test for nonsevere heritable platelet function disorders?

Five Years' Experience with Gene Panel Sequencing in Hereditary Hemolytic Anemia Screened by Routine Peripheral Blood Smear Examination

Genotype Imputation and Reference Panel: a Systematic Evaluation on Haplotype Size and Diversity.

Polymorphisms of the Human Platelet Antigen-1, -2, -3, -5, and -15 Systems and Acute Cellular Liver Transplant Rejection.